AIMS/HYPOTHESIS: Our aim was to examine the change in the management of hypertension in patients with Type I (insulin-dependent) diabetes mellitus in Europe, between 1989-1990 and 1997-1999. METHODS: Seven-year changes in hypertension treatment and control (defined as blood pressure <130/85 mmHg) were examined in a large sample of Type I diabetic patients recruited from 26 centres involved in the EURODIAB Prospective Complications Study. Hypertension was defined as a systolic and/or diastolic blood pressure greater than 140 and/or 90 mmHg respectively, and/or use of blood pressure lowering drugs. RESULTS: Of 1866 Type I diabetic patients, 412 had hypertension at baseline and 631 at follow-up. A greater proportion of hypertensive patients were treated at follow-up (69% vs 40%, p<0.0001), which persisted after adjustment for age or centre. Of those who were treated, a modest increase in the proportion of those controlled for hypertension was found (41% vs 32%, p=0.048), which disappeared after adjustment for age. Among hypertensive patients with albuminuria, the proportions treated also increased, from 35% to 76% ( p<0.0001) in microalbuminuric and 64% to 95% ( p<0.0001) in macroalbuminuric patients. Control of hypertension in albuminuric patients did not change significantly and was below 50%. The use of more than one anti-hypertensive drug increased over a 7-year period, from 19% to 33% ( p<0.0001), and a marked increase was shown in the proportion of those taking an ACE inhibitor (from 57% to 82%, p<0.0001). CONCLUSION/ INTERPRETATION: The management of hypertension in Type I diabetic patients across Europe has improved over a 7-year follow-up period. Optimal levels of blood pressure treatment and optimal levels of control have not yet been achieved.
AIMS/HYPOTHESIS: Our aim was to examine the change in the management of hypertension in patients with Type I (insulin-dependent) diabetes mellitus in Europe, between 1989-1990 and 1997-1999. METHODS: Seven-year changes in hypertension treatment and control (defined as blood pressure <130/85 mmHg) were examined in a large sample of Type I diabeticpatients recruited from 26 centres involved in the EURODIAB Prospective Complications Study. Hypertension was defined as a systolic and/or diastolic blood pressure greater than 140 and/or 90 mmHg respectively, and/or use of blood pressure lowering drugs. RESULTS: Of 1866 Type I diabeticpatients, 412 had hypertension at baseline and 631 at follow-up. A greater proportion of hypertensivepatients were treated at follow-up (69% vs 40%, p<0.0001), which persisted after adjustment for age or centre. Of those who were treated, a modest increase in the proportion of those controlled for hypertension was found (41% vs 32%, p=0.048), which disappeared after adjustment for age. Among hypertensivepatients with albuminuria, the proportions treated also increased, from 35% to 76% ( p<0.0001) in microalbuminuric and 64% to 95% ( p<0.0001) in macroalbuminuric patients. Control of hypertension in albuminuric patients did not change significantly and was below 50%. The use of more than one anti-hypertensive drug increased over a 7-year period, from 19% to 33% ( p<0.0001), and a marked increase was shown in the proportion of those taking an ACE inhibitor (from 57% to 82%, p<0.0001). CONCLUSION/ INTERPRETATION: The management of hypertension in Type I diabeticpatients across Europe has improved over a 7-year follow-up period. Optimal levels of blood pressure treatment and optimal levels of control have not yet been achieved.
Authors: F Collado-Mesa; H M Colhoun; L K Stevens; J Boavida; J B Ferriss; B Karamanos; P Kempler; G Michel; G Roglic; J H Fuller Journal: Diabet Med Date: 1999-01 Impact factor: 4.359
Authors: N Chaturvedi; A K Sjolie; J M Stephenson; H Abrahamian; M Keipes; A Castellarin; Z Rogulja-Pepeonik; J H Fuller Journal: Lancet Date: 1998-01-03 Impact factor: 79.321
Authors: J W M Nin; I Ferreira; C G Schalkwijk; M H Prins; N Chaturvedi; J H Fuller; C D A Stehouwer Journal: Diabetologia Date: 2009-01-30 Impact factor: 10.122
Authors: Marilia B Gomes; Lucianne Righeti Monteiro Tannus; Alessandra Saldanha de Mattos Matheus; Roberta Arnoldi Cobas; Catia C Sousa Palma; Aline Tiemi Kano Silva; Carlos Antonio Negrato; Sergio Atala Dib; Melanie Rodacki; João Soares Felício; Luis Henrique Canani Journal: Int J Hypertens Date: 2013-03-04 Impact factor: 2.420
Authors: Carmen de Burgos-Lunar; Rodrigo Jiménez-García; Miguel A Salinero-Fort; Paloma Gómez-Campelo; Angel Gil; Juan C Abánades-Herranz; Juan Cárdenas-Valladolid; Isabel del Cura-González Journal: PLoS One Date: 2014-01-27 Impact factor: 3.240